Press Releases on September 28, 2019 - EIN Presswire - Press Release Distribution Service

Published on September 28, 2019 - 11:30 GMT

Aileron Presents Positive Interim Phase 2a Data for ALRN-6924 in Combination with Pfizer’s Palbociclib at the 2019 Congress of the ...

WATERTOWN, Mass., Sept. 28, 2019 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, cell-permeating peptides to treat cancer patients, announced the presentation of interim results from its …

Distribution channels: Media, Advertising & PR ...

Published on September 28, 2019 - 08:15 GMT

G1 Therapeutics Presents Updated Data at ESMO 2019 from Randomized Phase 2 Trial of Trilaciclib in Combination with Chemotherapy ...

-- Trial results published simultaneously in The Lancet Oncology -- -- Company also to present updated Phase 2 results demonstrating myelopreservation benefits in small cell lung cancer (SCLC) patients receiving trilaciclib and chemotherapy in combination …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on September 28, 2019 - 06:30 GMT

Data From Randomized Phase 2 ENTRATA Study Demonstrate Telaglenastat with Everolimus Improves Progression-Free Survival in Renal ...

Data shared today in oral presentation at ESMO Congress 2019 show telaglenastat doubles median progression-free survival (PFS) in heavily pre-treated patients with advanced disease, reduced risk of death by 36% (HR=0.64, p=0.079 one-sided) First …

Distribution channels: Media, Advertising & PR, Technology ...

Published on September 28, 2019 - 05:21 GMT

MarketReview.com Releases Report on Bond Yields & Stock Investing

LOS ANGELES, Sept. 28, 2019 (GLOBE NEWSWIRE) -- MarketReview.com, a leading finance information website recently released a report on relationship between bond yields and stocks investing. According to the report, there are two main reasons why people …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on September 28, 2019 - 02:50 GMT

SHAREHOLDER ALERT: CLAIMSFILER REMINDS EVH, TWOU, TXT, VAL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

NEW ORLEANS, Sept. 27, 2019 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: 2U, Inc. (TWOU) Class Period: 2/26/2018 - 7/30/2019 Lead …

Distribution channels: IT Industry, Law ...

Published on September 28, 2019 - 02:50 GMT

SHAREHOLDER ALERT: CLAIMSFILER REMINDS MDP, PUMP INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

NEW ORLEANS, Sept. 27, 2019 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Meredith Corporation (MDP) Class Period: 5/10/2018-9/4/2019 Lead …

Distribution channels: IT Industry, Law ...

Published on September 28, 2019 - 02:50 GMT

SHAREHOLDER ALERT: CLAIMSFILER REMINDS CVS, GVA, IFF, PS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

NEW ORLEANS, Sept. 27, 2019 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: International Flavors & Fragrances Inc. (IFF) Class Period: 5 …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on September 28, 2019 - 02:50 GMT

SHAREHOLDER ALERT: CLAIMSFILER REMINDS FTCH, GNLN, OLLI, VRAY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

NEW ORLEANS, Sept. 27, 2019 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Greenlane Holdings, Inc. (GNLN) Class Period: shares issued …

Distribution channels: IT Industry, Law ...

Published on September 28, 2019 - 02:30 GMT

CytoDyn Treats First Patient in Phase 1b/2 Clinical Trial with Leronlimab (PRO 140) for Patients with Treatment-Naïve, Metastatic ...

VANCOUVER, Washington, Sept. 27, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 28, 2019 - 00:34 GMT

President wishes Prince Harry well in his commitment to demining

Luanda, ANGOLA, September 27 - The President of the Republic, João Lourenço, Friday expressed the hope that Prince Harry has started a renewed commitment towards demining in all countries by 2025, in continuation of the work idealised by his mother, …

Distribution channels:

Published on September 28, 2019 - 00:00 GMT

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against electroCore, Inc. (ECOR)

NEW YORK, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against electroCore, Inc. (“electroCore” or the “Company”) (Nasdaq: ECOR) in the United States District Court for the District …

Distribution channels: Consumer Goods, Law ...